These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 2177598)

  • 1. [Lessening the risk of transmission of hepatitis C virus by labile blood products: a role for indirect markers?].
    Jullien AM; Courouce AM; Maniez M; Brevière D; Menault M; Finetti P; Girard M
    Rev Fr Transfus Hemobiol; 1990 Oct; 33(5):355-8. PubMed ID: 2177598
    [No Abstract]   [Full Text] [Related]  

  • 2. [Anti-HVC and blood donors. Epidemiologic study of anti-HVC antibodies and the relation to indirect markers (ALT, anti-HBc)].
    Janot C
    Rev Fr Transfus Hemobiol; 1990 Oct; 33(5):347-50. PubMed ID: 2177596
    [No Abstract]   [Full Text] [Related]  

  • 3. [Anti-HVC antibodies and recipients of blood products: preliminary results of a prospective survey performed at a Parisian C. H. U].
    Lunel F; Azar N; Fournel JJ; Valla D; Foucault C; Habibi B; Jaulmes D; Perrin M; Opolon P; Huraux JM
    Rev Fr Transfus Hemobiol; 1990 Oct; 33(5):361-7. PubMed ID: 2177600
    [No Abstract]   [Full Text] [Related]  

  • 4. [Anti-HCV antibodies and transfusion recipients. Bibliographic data and current knowledge].
    Couroucé AM
    Rev Fr Transfus Hemobiol; 1990 Oct; 33(5):335-8. PubMed ID: 2177594
    [No Abstract]   [Full Text] [Related]  

  • 5. [Incidence of anti-HCV and ALT in blood donors].
    Martín Y; Marzo L; Cinto F; Delgado P; Buñuel C
    Sangre (Barc); 1990 Jun; 35(3):197-200. PubMed ID: 2118686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibodies to hepatitis C virus in blood donors and polytransfused patients of Macau (southeast China).
    Martins IA; Ling RC; Fai EL; Chai H; do Rosário Vong MA; de Olim GA
    Vox Sang; 1993; 65(3):245-6. PubMed ID: 7504374
    [No Abstract]   [Full Text] [Related]  

  • 7. Second generation anti-HCV test: seroprevalence in hemodialysis patients and blood donors.
    Holzberger G; Seidl S; Peschke B; Scheuermann EH; Schoeppe W
    Transplant Proc; 1992 Dec; 24(6):2648-9. PubMed ID: 1334595
    [No Abstract]   [Full Text] [Related]  

  • 8. [European Acute Transfusion Hepatitis Interferon Study (EATHIS)].
    Jullien AM; Dejean AM; Janot C; Trepo C
    Rev Fr Transfus Hemobiol; 1992 Jul; 35(3):199-204. PubMed ID: 1329792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Anti-HCV antibodies among blood donors in Cantabria. Incidence and relation to transaminase levels].
    Pastor JM; Hermosa V; Ruiz Tagle MA; Zubizarreta A
    Sangre (Barc); 1990 Jun; 35(3):205-7. PubMed ID: 2118687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibodies to hepatitis C and surrogate markers in blood donors.
    Koerner K; Stampe D; Glück D; Kubanek B
    Vox Sang; 1991; 61(2):138-9. PubMed ID: 1662427
    [No Abstract]   [Full Text] [Related]  

  • 11. Low incidence of non-A, non-B post-transfusion hepatitis in London confirmed by hepatitis C virus serology.
    Contreras M; Barbara JA; Anderson CC; Ranasinghe E; Moore C; Brennan MT; Howell DR; Aloysius S; Yardumian A
    Lancet; 1991 Mar; 337(8744):753-7. PubMed ID: 1672391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibody to hepatitis-C-virus-related proteins in sera from alanine-aminotransferase-screened blood donors and prospectively studied recipients.
    Widell A; Sundström G; Hansson BG; Moestrup T; Nordenfelt E
    Vox Sang; 1991; 60(1):28-33. PubMed ID: 1647082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Anti-HCV antibodies and post-transfusional non-A, non-B hepatitis].
    Smilovici W; Trepo C; Marinière AM; Ducos J
    Rev Fr Transfus Hemobiol; 1990 Oct; 33(5):359-60. PubMed ID: 2177599
    [No Abstract]   [Full Text] [Related]  

  • 14. Note on the measurement of alanine aminotransferase in the screening of blood donors.
    Dorizzi RM; Schiavon R; Disperati A; Chiavolini P; Capuzzo E
    Vox Sang; 1992; 62(4):246-7. PubMed ID: 1642006
    [No Abstract]   [Full Text] [Related]  

  • 15. [Hepatitis C].
    Lissen E; Pineda JA
    Enferm Infecc Microbiol Clin; 1991; 9(6):320-2. PubMed ID: 1657206
    [No Abstract]   [Full Text] [Related]  

  • 16. Also with a restrictive transfusion policy, screening with second-generation anti-hepatitis C virus enzyme-linked immunosorbent assay would have reduced post-transfusion hepatitis C after open-heart surgery.
    Mathiesen UL; Karlsson E; Foberg U; Frydén A; Franzén L; Widell A; Bodemar G
    Scand J Gastroenterol; 1993 Jul; 28(7):581-4. PubMed ID: 7689744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Anti-HVC antibodies and raw-material plasma: reflections and strategy].
    Avenard G; Maquin A; Schoeffter C; Mangin C
    Rev Fr Transfus Hemobiol; 1990 Oct; 33(5):351-4. PubMed ID: 2177597
    [No Abstract]   [Full Text] [Related]  

  • 18. [Hepatitis C virus and transfusion: policy regarding the donation and the donor. Groupe "Hépatites Virales" de la Société Nationale de Transfusion Sanguine].
    Moncharmont P; Janot C; Boudart D; Cotte C; Couroucé AM; Elghouzzi MH; Jullien AM; Lemaire JM; Maisonneuve P; Maniez-Montreuil M
    Rev Fr Transfus Hemobiol; 1992 Jul; 35(3):205-10. PubMed ID: 1329793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-A, non-B hepatitis and the anti-HCV assay.
    Barbara JA; Contreras M
    Vox Sang; 1991; 60(1):1-7. PubMed ID: 1711260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transfusion-associated non-A, non-B hepatitis: an assessment of the causative agent and its clinical impact.
    Alter HJ; Prince AM
    Transfus Med Rev; 1988 Dec; 2(4):288-93. PubMed ID: 2856531
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.